Skip to content

Clinical Performance of Habitual Wearers of Avaira Toric When Refitted With Clariti Toric Lenses

Clinical Performance of Habitual Wearers of Avaira Toric (Enfilcon A) When Refitted With Clariti Toric (Somofilcon A) Lenses for 1 Month.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02248766
Enrollment
30
Registered
2014-09-25
Start date
2014-09-30
Completion date
2014-10-31
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

The aim of this dispensing study is to evaluate the clinical performance of existing wearers of Avaira toric lenses following a refit with Clariti toric over 1 month of daily wear.

Detailed description

This is a 30-subject, prospective dispensing study comparing the clinical performance of the subjects' habitual Avaira toric lenses following a refit with Clariti toric lenses. Subject's habitual Avaira toric lenses will be evaluated at the first visit and then re-fitted with a pair of Clariti toric lenses for 1 month of daily wear. After the dispensing visit, subjects will return for evaluations at 1 week, 2 weeks and 4 weeks.

Interventions

somofilcon A lens

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Is between 18 and 40 years of age (inclusive) * Has had a self-reported visual exam in the last two years * Is an adapted Avaira toric contact lens (CL) wearer (at least 1 week of wear in Avaira toric) * Has a contact lens spherical prescription between +6.00 to - 8.00 (inclusive) * Have no less than 0.75D of astigmatism and no more than 1.75 D in both eyes. * Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye. * Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses. * Has clear corneas and no active ocular disease * Has read, understood and signed the information consent letter. * Patient contact lens refraction should fit within the available parameters of the study lenses. * Is willing to comply with the wear schedule (at least 5 days per week, \> 8 hours/day assuming there are no contraindications for doing so). * Is willing to comply with the visit schedule

Exclusion criteria

* Is not a habitual wearer of Avaira toric lenses * Has a CL prescription outside the range of the available parameters of the study lenses. * Has a spectacle cylinder less than -0.75D or more than -1.75 D of cylinder in either eye. * Has a history of not achieving comfortable CL wear (5 days per week; \> 8 hours/day) * Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye. * Presence of clinically significant (grade 2-4) anterior segment abnormalities * Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear. * Slit lamp findings that would contraindicate contact lens wear such as: * Pathological dry eye or associated findings * Pterygium, pinguecula, or corneal scars within the visual axis * Neovascularization \> 0.75 mm in from of the limbus * Giant papillary conjunctivitis (GCP) worse than grade 1 * Anterior uveitis or iritis (past or present) * Seborrheic eczema, Seborrheic conjunctivitis * History of corneal ulcers or fungal infections * Poor personal hygiene * Has a known history of corneal hypoesthesia (reduced corneal sensitivity) * Has aphakia, keratoconus or a highly irregular cornea. * Has Presbyopia or has dependence on spectacles for near work over the contact lenses. * Has undergone corneal refractive surgery. * Is participating in any other type of eye related clinical or research study.

Design outcomes

Primary

MeasureTime frameDescription
Visual Acuity - Enfilcon A and Somofilcon ABaseline, 1 week, 2 week, 4 weekMonocular and binocular logMAR visual acuity for enfilcon A / somofilcon A assessed at baseline and somofilcon A lenses assessed at 1 week, 2 week, 4 week.
Subjective Assessments- Enfilcon A and Somofilcon ABaseline, 1 week, 2 week, 4 weekSubjective assessments for: comfort, dryness, handling, overall lens fit, and overall vision satisfaction. Enfilcon A was assessed at baseline and somofilcon A lenses assessed at 1 week, 2 week, 4 week. Scale(s): comfort (0=very poor; 10=excellent), dryness (0=very dry; 10=no dryness), handling (0=very difficult; 10=very easy), overall lens fit (0=very unstable; 10=very stable), overall vision satisfaction (0=very unsatisfied; 10=very satisfied)

Countries

Spain

Participant flow

Participants by arm

ArmCount
Enfilcon A / Somofilcon A
All participants are habitual wearers of enfilcon A lens and who are refitted with somofilcon A lens enfilcon A: All participants wear habitual enfilcon A lens first and then refitted with somofilcon A lens somofilcon A: All participants wear habitual enfilcon A lens first and then refitted with somofilcon A lens
30
Total30

Baseline characteristics

CharacteristicEnfilcon A / Somofilcon A
Age, Continuous23.4 years
STANDARD_DEVIATION 2.7
Region of Enrollment
Spain
30 participants
Sex: Female, Male
Female
19 Participants
Sex: Female, Male
Male
11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 300 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

Primary

Subjective Assessments- Enfilcon A and Somofilcon A

Subjective assessments for: comfort, dryness, handling, overall lens fit, and overall vision satisfaction. Enfilcon A was assessed at baseline and somofilcon A lenses assessed at 1 week, 2 week, 4 week. Scale(s): comfort (0=very poor; 10=excellent), dryness (0=very dry; 10=no dryness), handling (0=very difficult; 10=very easy), overall lens fit (0=very unstable; 10=very stable), overall vision satisfaction (0=very unsatisfied; 10=very satisfied)

Time frame: Baseline, 1 week, 2 week, 4 week

ArmMeasureGroupValue (MEAN)Dispersion
Enfilcon ASubjective Assessments- Enfilcon A and Somofilcon AComfort on insertion8.53 units on a scaleStandard Deviation 1
Enfilcon ASubjective Assessments- Enfilcon A and Somofilcon AOverall dryness8.03 units on a scaleStandard Deviation 0.67
Enfilcon ASubjective Assessments- Enfilcon A and Somofilcon AComfort prior to removal8.13 units on a scaleStandard Deviation 0.94
Enfilcon ASubjective Assessments- Enfilcon A and Somofilcon AHandling9.23 units on a scaleStandard Deviation 0.63
Enfilcon ASubjective Assessments- Enfilcon A and Somofilcon AOverall vision satisfaction8.30 units on a scaleStandard Deviation 0.79
Enfilcon ASubjective Assessments- Enfilcon A and Somofilcon AComfort overall8.10 units on a scaleStandard Deviation 0.92
Enfilcon ASubjective Assessments- Enfilcon A and Somofilcon ADryness during the day8.47 units on a scaleStandard Deviation 0.73
Enfilcon ASubjective Assessments- Enfilcon A and Somofilcon AOverall lens fit7.93 units on a scaleStandard Deviation 0.69
Enfilcon ASubjective Assessments- Enfilcon A and Somofilcon ADryness prior to removal8.23 units on a scaleStandard Deviation 0.73
Somofilcon A at 1 WeekSubjective Assessments- Enfilcon A and Somofilcon ADryness during the day8.27 units on a scaleStandard Deviation 0.64
Somofilcon A at 1 WeekSubjective Assessments- Enfilcon A and Somofilcon AHandling9.20 units on a scaleStandard Deviation 0.55
Somofilcon A at 1 WeekSubjective Assessments- Enfilcon A and Somofilcon AComfort overall7.63 units on a scaleStandard Deviation 0.77
Somofilcon A at 1 WeekSubjective Assessments- Enfilcon A and Somofilcon AOverall dryness7.77 units on a scaleStandard Deviation 0.73
Somofilcon A at 1 WeekSubjective Assessments- Enfilcon A and Somofilcon AOverall vision satisfaction8.10 units on a scaleStandard Deviation 0.69
Somofilcon A at 1 WeekSubjective Assessments- Enfilcon A and Somofilcon AOverall lens fit7.90 units on a scaleStandard Deviation 0.78
Somofilcon A at 1 WeekSubjective Assessments- Enfilcon A and Somofilcon AComfort prior to removal7.83 units on a scaleStandard Deviation 0.8
Somofilcon A at 1 WeekSubjective Assessments- Enfilcon A and Somofilcon AComfort on insertion8.43 units on a scaleStandard Deviation 0.62
Somofilcon A at 1 WeekSubjective Assessments- Enfilcon A and Somofilcon ADryness prior to removal8.00 units on a scaleStandard Deviation 0.79
Somofilcon A at 2 WeekSubjective Assessments- Enfilcon A and Somofilcon ADryness prior to removal7.33 units on a scaleStandard Deviation 0.8
Somofilcon A at 2 WeekSubjective Assessments- Enfilcon A and Somofilcon ADryness during the day7.63 units on a scaleStandard Deviation 0.88
Somofilcon A at 2 WeekSubjective Assessments- Enfilcon A and Somofilcon AComfort on insertion8.07 units on a scaleStandard Deviation 0.64
Somofilcon A at 2 WeekSubjective Assessments- Enfilcon A and Somofilcon AComfort prior to removal7.20 units on a scaleStandard Deviation 0.71
Somofilcon A at 2 WeekSubjective Assessments- Enfilcon A and Somofilcon AComfort overall7.10 units on a scaleStandard Deviation 0.76
Somofilcon A at 2 WeekSubjective Assessments- Enfilcon A and Somofilcon AOverall dryness7.13 units on a scaleStandard Deviation 0.86
Somofilcon A at 2 WeekSubjective Assessments- Enfilcon A and Somofilcon AHandling9.17 units on a scaleStandard Deviation 0.46
Somofilcon A at 2 WeekSubjective Assessments- Enfilcon A and Somofilcon AOverall lens fit7.77 units on a scaleStandard Deviation 0.76
Somofilcon A at 2 WeekSubjective Assessments- Enfilcon A and Somofilcon AOverall vision satisfaction7.60 units on a scaleStandard Deviation 0.67
Somofilcon A at 4 WeekSubjective Assessments- Enfilcon A and Somofilcon AHandling9.00 units on a scaleStandard Deviation 0.53
Somofilcon A at 4 WeekSubjective Assessments- Enfilcon A and Somofilcon ADryness during the day7.43 units on a scaleStandard Deviation 1.13
Somofilcon A at 4 WeekSubjective Assessments- Enfilcon A and Somofilcon AComfort overall6.20 units on a scaleStandard Deviation 1.1
Somofilcon A at 4 WeekSubjective Assessments- Enfilcon A and Somofilcon AOverall vision satisfaction7.77 units on a scaleStandard Deviation 0.62
Somofilcon A at 4 WeekSubjective Assessments- Enfilcon A and Somofilcon AOverall lens fit8.13 units on a scaleStandard Deviation 0.7
Somofilcon A at 4 WeekSubjective Assessments- Enfilcon A and Somofilcon AComfort prior to removal6.70 units on a scaleStandard Deviation 0.99
Somofilcon A at 4 WeekSubjective Assessments- Enfilcon A and Somofilcon AOverall dryness6.70 units on a scaleStandard Deviation 1.23
Somofilcon A at 4 WeekSubjective Assessments- Enfilcon A and Somofilcon ADryness prior to removal7.03 units on a scaleStandard Deviation 0.96
Somofilcon A at 4 WeekSubjective Assessments- Enfilcon A and Somofilcon AComfort on insertion7.50 units on a scaleStandard Deviation 0.86
Primary

Visual Acuity - Enfilcon A and Somofilcon A

Monocular and binocular logMAR visual acuity for enfilcon A / somofilcon A assessed at baseline and somofilcon A lenses assessed at 1 week, 2 week, 4 week.

Time frame: Baseline, 1 week, 2 week, 4 week

ArmMeasureGroupValue (MEAN)Dispersion
Enfilcon AVisual Acuity - Enfilcon A and Somofilcon ABinocular-0.033 logMarStandard Deviation 0.05
Enfilcon AVisual Acuity - Enfilcon A and Somofilcon AOculus Dexter (OD)-0.013 logMarStandard Deviation 0.03
Enfilcon AVisual Acuity - Enfilcon A and Somofilcon AOculus Sinister (OS)-0.010 logMarStandard Deviation 0.03
Somofilcon A at 1 WeekVisual Acuity - Enfilcon A and Somofilcon ABinocular-0.033 logMarStandard Deviation 0.05
Somofilcon A at 1 WeekVisual Acuity - Enfilcon A and Somofilcon AOculus Sinister (OS)-0.010 logMarStandard Deviation 0.03
Somofilcon A at 1 WeekVisual Acuity - Enfilcon A and Somofilcon AOculus Dexter (OD)-0.013 logMarStandard Deviation 0.03
Somofilcon A at 2 WeekVisual Acuity - Enfilcon A and Somofilcon AOculus Dexter (OD)-0.010 logMarStandard Deviation 0.03
Somofilcon A at 2 WeekVisual Acuity - Enfilcon A and Somofilcon AOculus Sinister (OS)-0.017 logMarStandard Deviation 0.03
Somofilcon A at 2 WeekVisual Acuity - Enfilcon A and Somofilcon ABinocular-0.040 logMarStandard Deviation 0.05
Somofilcon A at 4 WeekVisual Acuity - Enfilcon A and Somofilcon ABinocular-0.040 logMarStandard Deviation 0.05
Somofilcon A at 4 WeekVisual Acuity - Enfilcon A and Somofilcon AOculus Dexter (OD)-0.023 logMarStandard Deviation 0.03
Somofilcon A at 4 WeekVisual Acuity - Enfilcon A and Somofilcon AOculus Sinister (OS)-0.017 logMarStandard Deviation 0.03

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026